Debut Biotechnology, Inc., a L’Oreal SA-backed company that recently expanded its partnership with the beauty giant, launches BiotechXBeautyLabs, a development and contract manufacturing business that it says provides biotechnology access to companies that previously could not afford it.
Debut ‘Democratizes’ Biotech Product Formulation, Promising Superior Claims, Sustainability
San Diego-based Debut Biotechnology, Inc., which recently expanded an ingredient development partnership with L’Oréal SA, has launched BiotechXBeautyLabs development and contract manufacturing to make it possible for all brands – even those without expertise, proprietary ingredients or investment capability – to join the biotech revolution.
More from Innovation & IP
• By
RoC launches RoC 35 Protocol, a five-product regimen backed by the brand’s largest clinical assessment yet, showing 200 subjects saw significant improvement in ‘key parameters’ of skin aging.
• By
Church & Dwight Co. Inc. will launch a new body acne patch under its Hero Mighty Patch range, a light dry shampoo formula for Batiste and three new initiatives for vitafusion gummies, the firm reported during its Analyst Day 31 January.
• By
French beauty giant L’Oréal SA enters a partnership with New York-based technology company IBM for an industry first-of-its-kind AI foundation model to spur product development and reformulation and make strides in sustainability.
• By
Eucerin Radiant Tone Collection comprises five products centered on the brand’s wildly popular ingredient Thiamidol, currently the most effective inhibitor of human tyrosinase, an enzyme that contributes to skin hyperpigmentation.
More from Ingredients & Safety
• By
UK food toxicity committee says substantial exceedances of the Acceptable Daily Intake of turmeric - such as through excessive supplement use - represents a potential health risk to humans.
• By
The Expert Panel for Cosmetic Ingredient Safety issued a revised tentative amended report for p-phenylenediamine and related ingredients during its 171st meeting.
• By
FSA now aims to send the first recommendations for the authorization of CBD novel food products to UK government ministers in 2025, according to its most recent board meeting. The agency is closely scrutinizing trace THC levels and is planning to ban use of CBD food products by under 18s.